Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

HHS.gov
  • About HHS
  • Programs & Services
  • Grants & Contracts
  • Laws & Regulations

Breadcrumb

  1. Home
  2. About
  3. News
  4. On First Anniversary of the President’s Reignited Cancer Moonshot, the Biden-Harris Administration Awards Nearly $11 Million to Address Disparities in Cancer Screening and Follow-Up Care
  • News
  • Blog
  • HHS Live
  • Podcasts
  • Media Guidelines for HHS Employees
FOR IMMEDIATE RELEASE
February 2, 2023
Contact: HHS Press Office
202-690-6343
media@hhs.gov

On First Anniversary of the President’s Reignited Cancer Moonshot, the Biden-Harris Administration Awards Nearly $11 Million to Address Disparities in Cancer Screening and Follow-Up Care

The Health Resources and Services Administration doubles its investment in a first-of-its-kind initiative to accelerate access to cancer screening and connection to follow-up treatment, including patient navigation support services, in underserved communities

Today, the U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), awarded nearly $11 million to 22 HRSA-funded health centers to improve access to life-saving cancer screenings and early detection services for underserved communities. These awards double support for an initiative launched last year by the Biden-Harris Administration through which HRSA-funded health centers are working to close the cancer screening gap and decrease the impact of preventable cancers.

“At HHS, we are doing all we can to make cancer prevention and screening services accessible to everyone in the United States,” said HHS Secretary Xavier Becerra. “Today’s investment in health centers is another step towards reducing disparities in cancer screenings across races, ethnicities, genders, and incomes—which is essential to realizing the President’s goal of ending cancer as we know it. This is also the latest action HHS is taking to address the estimated 9.5 million cancer screenings missed during the pandemic.”

One year ago, President Biden reignited the Cancer Moonshot and set new national goals to cut the death rate from cancer by at least 50% over the next 25 years and improve the experience of people and their families living with and surviving cancer.

“Early identification and early treatment are essential to meeting the President’s goal of slashing the cancer death rate. Yet, many families living in underserved communities face challenges in getting life-saving cancer screenings and treatment. We have to remove these obstacles and make it easier not only to get screened but to get connected to care,” said HRSA Administrator Carole Johnson.  “That’s why HRSA is proud to double our investment in partnerships between our community health centers and National Cancer Institute-Designated Cancer Centers to expand lifesaving screenings and early detection services and make early intervention easier for those who live in underserved communities. Today’s investment is a critical down-payment on reaching the Cancer Moonshot’s goals.”

Cancer is the second-leading cause of death in the United States, with approximately 600,000 deaths annually. Appropriate screening and timely follow-up care help to detect and prevent cancer. Yet, significant disparities continue to exist in cancer screening and follow-up care, including disparities based on an individual’s income, insurance status, and race or ethnicity.

The $11 million in 2023 awards doubles HRSA’s investment in the Accelerating Cancer Screening Program from $5 million in 2022. The program focuses on leveraging outreach specialists and patient navigators to conduct patient outreach in underserved communities served by health centers to promote early detection of cancer, connect patients to screening services, and provide hands-on assistance with accessing high quality cancer care and treatment as needed. Today’s awardees, listed below, join HRSA’s Fiscal Year 2022 Accelerating Cancer Screening Program health center awardees from Virginia, Texas, Tennessee, Oklahoma, Kansas, Florida, and California.

To locate a HRSA-supported health center, visit: https://findahealthcenter.hrsa.gov.

See the table below for a full list of the Fiscal Year 2023 Accelerating Cancer Screening awardees announced today:

Health Center City State Award Amount
ARcare Augusta Arkansas $500,000
North Country Healthcare, Inc. Flagstaff Arizona $500,000
JWCH Institute, Inc. Commerce California $500,000
UC Irvine, Family Health Care Irvine California $500,000
AltaMed Health Services Corporation Los Angeles California $500,000
Northeast Valley Health Corporation San Fernando California $500,000
Plan De Salud Del Valle, Inc. Fort Lupton Colorado $500,000
Community Health Center, Incorporated Middletown Connecticut $500,000
Fair Haven Community Health Clinic Inc New Haven Connecticut $500,000
Heartland International Health Centers Chicago Illinois $499,318
North End Community Health Committee, Inc. Boston Massachusetts $500,000
Community Health Center of Cape Cod, Inc. Mashpee Massachusetts $500,000
Whittier Street Health Center Roxbury Massachusetts $500,000
Packard Health, Inc. Ann Arbor Michigan $500,000
Family Health Care Clinic, Inc. Pearl Mississippi $500,000
Roanoke Chowan Community Health Center, Inc. Ahoskie North Carolina $425,286
Gaston Family Health Services, Inc. Gastonia North Carolina $499,508
Community Health Center of Buffalo, Inc. Buffalo New York $500,000
Refuah Health Center, Inc. Spring Valley New York $500,000
Primary Health Network Sharon Pennsylvania $500,000
Matagorda Episcopal Health Outreach Program Corporation Bay City Texas $500,000
St Charles Health Council Inc. Jonesville Virginia $500,000

For a list of the Fiscal Year 2022 Accelerating Cancer Screening awardees, visit: https://bphc.hrsa.gov/funding/funding-opportunities/accelerating-cancer-screening/2022-awards

###
Note: All HHS press releases, fact sheets and other news materials are available at https://www.hhs.gov/news.
Like HHS on Facebook, follow HHS on Twitter @HHSgov, and sign up for HHS Email Updates.
Last revised: February 2, 2023

Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases

Sign Up

Subscribe to RSS

Receive latest updates

Subscribe to our RSS

Related News Releases

  • HHS and Baby2Baby Announce Partnership to Support New Mothers with a Newborn Supply Kit During Visit by Vice President Kamala Harris

  • New Surgeon General Advisory Raises Alarm about the Devastating Impact of the Epidemic of Loneliness and Isolation in the United States

  • HHS Awards Phase 1 Winners of Competition to Reduce Risk of Exposure to Endocrine-Disrupting Chemicals for Black Women

Related Blog Posts

  • HHS Blog thumbnail

    HHS Shines Spotlight on Diagnostic Innovation During Lyme Disease Awareness Month

  • An image of an adolescent girl smiling. The graphic says “April 3-7. Adolescent Immunization Action Week. #AIAW23.”

    It’s Time to Act! On-Time Immunization is Critical for All Adolescents

  • HHS Blog thumbnail

    ICYMI: 2025 Dietary Guidelines Advisory Committee Holds First Meeting

Media Inquiries

For general media inquiries, please contact media@hhs.gov.

Content created by ASPA Press Office
Content last reviewed February 2, 2023
Back to top
  • Contact HHS
  • Careers
  • HHS FAQs
  • Nondiscrimination Notice
  • HHS Archive
  • Accessibility
  • Privacy Policy
  • Viewers & Players
  • Budget/Performance
  • Inspector General
  • Web Site Disclaimers
  • EEO/No Fear Act
  • FOIA
  • The White House
  • USA.gov

Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases.

Sign Up
HHS Logo

HHS Headquarters

200 Independence Avenue, S.W.
Washington, D.C. 20201
Toll Free Call Center: 1-877-696-6775​